Latest Breaking News On - Special immunology - Page 1 : comparemela.com

Data confirm the effectiveness and safety of dolutegravir and raltegravir for infants, children, and adolescents living with HIV, but researchers say that long-term monitoring is needed.

United statesClaire townsendNatella rakhmaninaJournal of the internationalWorld health organizationChildren national hospitalServices special immunologySaharan africaSpecial immunologyNational hospitalMedscape medicalAntiretroviral therapyAntiretroviral therapy artHerapy antiretroviralPediatric hiv therapyIv therapy pediatric